Head-to-Head Comparison
| Criteria | Methylfolate | Folic Acid (Folate) | Winner |
|---|---|---|---|
| Bioavailability | High — directly usable, bypasses MTHFR enzyme | Variable — depends on MTHFR genotype and enzyme capacity | Methylfolate |
| Clinical Evidence | Moderate — strong mechanistic data, growing trial evidence | Very Strong — decades of fortification and NTD prevention data | Folic Acid (Folate) |
| GI Tolerability | Excellent — no unmetabolized folate concerns | Good — but unmetabolized folic acid (UMFA) may accumulate | Methylfolate |
| Cost | $0.20-0.40/serving | $0.03-0.10/serving | Folic Acid (Folate) |
| Pregnancy & Neural Tube Prevention | Strong — effective for all genotypes including MTHFR carriers | Strong — proven NTD prevention, but less effective for MTHFR carriers | Methylfolate |